Senior Manager, R&D Communications & Engagement |
Basel (City) |
Switzerland |
Corporate Affairs |
CTS |
Communications & Public Affairs |
6月 23, 2025 |
Associate Director, Policy Analytics |
Remote Position (USA) |
USA |
Corporate Affairs |
Universal Hierarchy Node |
Communications & Public Affairs |
6月 23, 2025 |
Executive Director, Portfolio Policy (Oncology) |
Basel (City) |
Switzerland |
Corporate Affairs |
Corporate |
Communications & Public Affairs |
6月 19, 2025 |
Patient Engagement Manager |
Bratislava |
Slovakia |
International |
Universal Hierarchy Node |
Communications & Public Affairs |
6月 19, 2025 |
Associate Director, Strategic Planning and Operations |
Washington, DC |
USA |
Corporate Affairs |
Universal Hierarchy Node |
Communications & Public Affairs |
6月 10, 2025 |
Sr Manager, Executive Communications |
Toranomon (NPKK Head Office) |
Japan |
Corporate Affairs |
Universal Hierarchy Node |
Communications & Public Affairs |
6月 09, 2025 |
AD, Patient Assistance Foundation - Operational Excellence |
East Hanover |
USA |
US |
Universal Hierarchy Node |
Communications & Public Affairs |
6月 02, 2025 |
Director, Cardio Renal (CRM), US Patient Advocacy |
East Hanover |
USA |
Corporate Affairs |
CTS |
Communications & Public Affairs |
5月 29, 2025 |
Communications & Patient Advocacy Manager |
Selangor |
Malaysia |
Corporate Affairs |
Innovative Medicines |
Communications & Public Affairs |
5月 28, 2025 |
Associate Director, Rare Hematology, US Patient Advocacy |
East Hanover |
USA |
Corporate Affairs |
Universal Hierarchy Node |
Communications & Public Affairs |
5月 27, 2025 |
Director, Corporate Leadership, US Patient Advocacy |
East Hanover |
USA |
Corporate Affairs |
CTS |
Communications & Public Affairs |
5月 27, 2025 |
Associate Director, Oncology, US Patient Advocacy |
East Hanover |
USA |
Corporate Affairs |
CTS |
Communications & Public Affairs |
5月 27, 2025 |
Brand Communications & Patient Advocacy Manager (f/m/d) |
Vienna |
Austria |
International |
Universal Hierarchy Node |
Communications & Public Affairs |
5月 22, 2025 |
Head of Public Affairs, Saudi Arabia |
Riyadh |
Saudi Arabia |
People & Organization |
Universal Hierarchy Node |
Communications & Public Affairs |
5月 19, 2025 |
Country Communications & Patient Advocacy Head, Korea |
Seoul |
South Korea |
International |
Sandoz |
Communications & Public Affairs |
5月 18, 2025 |
Country Communications & Patient Advocacy Head |
Bangkok |
Thailand |
Corporate Affairs |
Universal Hierarchy Node |
Communications & Public Affairs |
5月 16, 2025 |
TA Communications & Patient Advocacy Manager |
Amsterdam |
Netherlands |
Corporate Affairs |
Universal Hierarchy Node |
Communications & Public Affairs |
5月 14, 2025 |
Manager, Patient Engagement |
Shanghai (Shanghai) |
China |
Corporate Affairs |
Universal Hierarchy Node |
Communications & Public Affairs |
5月 13, 2025 |
TA Communications and Patient Advocacy Lead |
Istanbul Ataşehir |
Türkiye |
International |
CTS |
Communications & Public Affairs |
5月 09, 2025 |
Director, Communications (Finance) |
East Hanover |
USA |
Corporate Affairs |
CTS |
Communications & Public Affairs |
5月 09, 2025 |
Director, Strategy & Operations |
East Hanover |
USA |
Corporate Affairs |
CTS |
Communications & Public Affairs |
4月 30, 2025 |
Manager, Product Brand Comms |
Toranomon (NPKK Head Office) |
Japan |
Corporate Affairs |
Universal Hierarchy Node |
Communications & Public Affairs |
4月 22, 2025 |
Director, Public Affairs (Policy) |
Beijing (Beijing) |
China |
Corporate Affairs |
Innovative Medicines |
Communications & Public Affairs |
3月 10, 2025 |
Director, Corporate Communications, China |
Shanghai (Shanghai) |
China |
Corporate Affairs |
Universal Hierarchy Node |
Communications & Public Affairs |
3月 04, 2025 |
Manager, TA Patient Advocacy |
Shanghai (Shanghai) |
China |
Corporate Affairs |
Universal Hierarchy Node |
Communications & Public Affairs |
3月 04, 2025 |
Executive Director, Public Affairs Asia Aspiring |
Mapletree Business City (MBC) |
Singapore |
People & Organization |
Corporate |
Communications & Public Affairs |
2月 10, 2025 |